Roberto Moretti
Papers
2
Total Citations
45
H-Index
2
About
Roberto Moretti is a leading researcher in the field of radioguided surgery, with a particular focus on advancing precision oncology through novel intraoperative imaging technologies. His work centers on the development and evaluation of DROP-IN probes for robot-assisted procedures, specifically targeting prostate cancer. Moretti’s major contribution is the pioneering integration of beta-emitting PET isotopes—such as 68Ga-PSMA—into flexible, robot-compatible probes, a significant departure from traditional low-energy SPECT-based systems. His most cited paper (2020, 43 citations) provides the first ex vivo technology evaluation of a DROP-IN beta probe using prostate cancer specimens, demonstrating its potential for more sensitive and targeted tumor resection. This work bridges the gap between nuclear medicine and robotic surgery, offering a path toward improved surgical outcomes. Moretti’s research has garnered attention for its translational impact, laying the groundwork for clinical adoption of beta radioguidance in robot-assisted oncology. His achievements highlight a commitment to merging engineering innovation with surgical precision, making him a key figure in the evolution of radioguided interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2